Site Search

Led by two former Commissioners of the Federal Trade Commission (FTC)–one of whom also served as U.S. Assistant Attorney General for Antitrust at the Department of Justice (DOJ)–Cravath’s highly regarded antitrust practice provides a wealth of experience and insight with respect to formulating global antitrust strategy, securing regulatory clearance for mergers and acquisitions, and bringing or defending against charges of anticompetitive behavior. Clients turn to Cravath for their most significant—and often unprecedented—antitrust concerns, and we have played a central role in industry‑shaping competition matters for decades.

Cravath has an extensive track record of success in federal and state appellate courts across the country, for both appellants and appellees, repeatedly going “the distance in some of the thorniest, most complex trials and appeals” in the last several years. (The American Lawyer) We successfully defend positive results we achieve in the trial courts, including interlocutory appeals and appeals following trial or other disposition, and—in the face of adverse decisions—we persevere to obtain the best outcome for our clients, shaping the law in the process.

Cravath frequently and successfully represents U.S. and non-U.S. entities in domestic and international arbitrations involving diverse industries and various areas of the law. Our representations extend to clients in Asia, Europe, Latin America and the Middle East, as well as sovereign nations, often involving multibillion‑dollar disputes.

On September 12, 2025, Cravath prepared a memo for its clients entitled “IRS Publishes Guidance for Determining Beginning of Construction for Solar and Wind Projects.” The memo examines the Internal Revenue Service’s recently issued Notice 2025-42 (“New Guidance”), which sets forth new rules for determining “beginning of construction” for solar and wind projects seeking to claim clean electricity credits under Sections 45Y and 48E of the Internal Revenue Code.

On September 5, 2025, LMG Life Sciences honored Cravath at the publication’s 2025 Americas Awards, which recognize “top firms, attorneys and in‑house counsel for their work in the life sciences industry over the past year.” The Firm was honored with an Impact Deal of the Year award for its representation of Johnson & Johnson in its $14.6 billion acquisition of Intra Cellular Therapies, Inc.

Cravath represented Weyerhaeuser Company (“Weyerhaeuser”) and its subsidiary, Weyerhaeuser NR Company, in connection with its $800 million term loan facility. The proceeds were used to finance the partial redemption of Weyerhaeuser’s 4.75% senior unsecured notes due in 2026 and for general corporate purposes. Weyerhaeuser is one of the world’s largest private owners of timberlands. The transaction closed on August 25, 2025.

From the Firm’s inception, challenging pro bono work has been a cornerstone of our practice.

It takes more than great lawyers to make a great law firm. It takes an administrative staff that shares our lawyers’ commitment to quality and excellence. Cravath’s dedicated staff helps sustain our preeminent position among the world’s law firms. Our collaborative environment and singular record of success combine to provide you with an unparalleled opportunity to develop both professionally and personally.